Lenzilumab,Azacitidine
humanigen
['leukemia', 'humanigen', '$hgen']
humanigen presents promising new hematologic data from preach-m trial for chronic myelomonocytic leukemia treatment at the 2023 european hematology association congress - health stocks hub $hgen 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2